Here are three things to know:
1. Shai Yarkoni, MD, PhD, and Nuriel Chirich Kasbian co-founded the company in 2011.
2. Cellect recently received several patent grants for its Apograft technology, which is designed to replace costly and complex stem cell isolation methods.
3. Apograft-using devices are intended for bone marrow transplants, diabetes, inflammatory bowel disease, graft-versus-host-disease and more.
More articles on biologics:
Bio2 Technologies to begin enrolling patients in cervical interbody fusion device trial: 3 insights
3 things to know about Kuros Biosciences’ CEO
3 things to know about Histogenics
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
